-
How Will Psychedelics Become Medicine? A Scientific Review Of The Drug Development Pathway
Saturday, January 2, 2021 - 12:23pm | 1926Read More...This article was originally published on Microdose Psychedelic Insights and appears here with permission. MagicMed is a Key Player in the Psychedelic Medicine Development Process The current pharmaceutical regulatory process is, to say the least, inherently daunting for most drug...
-
Denied Medicine As A Punishment: Cannabis And Parole
Monday, October 12, 2020 - 9:46am | 1445Read More...This article was originally published on The Cannigma, and appears here with permission. If you’re a medical marijuana patient and you receive probation or are released on parole, will you still be legally allowed to use your medicine? It depends on where you live, and the answer is even more...
-
Cannabis Doesn't Cause Cognitive Decline, Twin Study Finds
Sunday, October 4, 2020 - 1:07pm | 1551Read More...This article was originally published on The Cannigma, and appears here with permission. Does cannabis use, medicinal or otherwise, have a long-term, negative impact on cognitive function? Years of studies have provided complex and often conflicting answers, particularly when it comes to teenage...
-
Regulators Approve GW Pharmaceuticals' Cannabis-based Epidyolex In Australia
Wednesday, September 23, 2020 - 9:34am | 323Read More...Epidyolex, the first FDA approved CBD medicine for severe epilepsy in children, received Australian Therapeutic Goods Administration approval. GW Pharmaceuticals plc (NASDAQ: GWPH) confirmed Wednesday that TGA authorized the medicine to treat Lennox-Gastaut syndrome (LGS) or Dravet...
-
Mind Medicine CEO Calls Compass IPO: A 'Clear Bellwether' For Psychedelic Space
Saturday, September 19, 2020 - 8:11am | 478Read More...On Friday, UK-based mental health care company Compass Pathways (NASDAQ: CMPS) announced it has begun trading on NASDAQ under the symbol CMPS. This is the first time a psychedelics company is listed on a major U.S. Stock Exchange. JR Rahn, CEO of psychedelics drug development company Mind...
-
Afya IPO: What You Need To Know
Wednesday, July 17, 2019 - 1:49pm | 339Read More...A Brazilian medical education company is tapping the IPO market this week. The IPO Terms Afya has filed to offer 13.74 million Class A common shares in an IPO, with 11.83 million shares to be sold by the company and the remaining 1.92 million shares by selling shareholders, according to the F-1/A...
-
3 Pharma Companies Investing In Cannabis-Related Treatments
Thursday, August 28, 2014 - 9:42am | 637Read More...For all the talk and, yes, hype about the marijuana industry's so-called “green rush,” the big pharmaceutical companies appeared to be giving cannabis-based treatments the cold shoulder because of federal laws outlawing marijuana. Given the legal, political and cultural inroads...
-
3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology
Sunday, August 24, 2014 - 7:08pm | 764Read More...Companies producing so-called “plantibodies,” or plant-produced antibodies created by genetic engineering, have been attracting headlines recently. San Diego-based Mapp Pharmaceutical, which was acquired last year by Allergan (NYSE: AGN), has gotten global attention over the...
-
Why Investors Should Closely Watch Celgene
Wednesday, August 6, 2014 - 3:53pm | 673Read More...We’re waist-deep into the earnings season, and many companies have already filed. The U.S. biotech firm Celgene Corp (NASDAQ: CELG) has filed as well, and its reported earnings beat Wall Street’s expectations. Here are some takeaways from the report. Earnings Overview Revenues...
-
3 Reasons To Buy Merck For The Long Term
Thursday, July 31, 2014 - 2:30pm | 355Read More...Merck (NYSE: MRK) is a blue chip "Big Pharma" stock that is up for the last week, month, quarter, six months and year of market action. For 2014, Merck has risen by nearly 19 percent. There are three reasons for long-term investors to buy shares of Merck in expectation that the share...
-
Pharmaceutical ETFs Are Health Care Sector Standouts
Tuesday, July 29, 2014 - 2:49pm | 468Read More...The health care sector has been on fire in 2014, as investors continue to bet on the development of new drugs and increased need for medical services. On Tuesday, the pharmaceuticals industry received a vote of confidence, after both Pfizer Inc (NYSE: PFE) and Merck & Co. (NYSE: MRK)...
-
2 Biotech Stocks With Massive Increases In Short Interest
Monday, July 28, 2014 - 3:30pm | 345Read More...Short interest can be a very telling component of investor and trader sentiment toward a stock. High or rising short interest typically means that investors and traders believe a stock is going to drop or continue a current decline further. However, high short interest can also be viewed as a...
-
Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results
Thursday, July 17, 2014 - 10:12am | 691Read More...Mixed news came out this week on research into Alzheimer's. New studies suggest the rate of Alzheimer's and other forms of dementia is dropping in the United States and other developed countries. Meanwhile, Big Pharma's years-long battle to find a treatment, if not a cure,...
-
5-Star Biotech Stock Watch: Aegerion Pharmaceuticals
Wednesday, July 9, 2014 - 2:30pm | 382Read More...The Nasdaq Composite got hammered Tuesday. The Russell was also slammed pretty hard. The Russell, in particular, broke a key trendline of support, which implies more selling to come. And if you’ve been in the market this year then Tuesday's price action reminds you of March and April...
-
Walgreen Co. Or CVS Caremark: Which Would You Rather?
Tuesday, July 8, 2014 - 2:35pm | 624Read More...The business of chain drugstores has been a veritable model for how just about any retail business should envision itself. Over the past 75 years, chain drugstores have seen staggeringly consistent growth while becoming an increasingly pervasive part of America's cultural landscape. With...
